- Home
- FLR vs LNTH Comparison
FLR vs LNTH Comparison
Compare FLR & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLR
- LNTH
- Stock Information
- Founded
- FLR 1912
- LNTH 1956
- Country
- FLR United States
- LNTH United States
- Employees
- FLR N/A
- LNTH N/A
- Industry
- FLR Military/Government/Technical
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- FLR Industrials
- LNTH Health Care
- Exchange
- FLR Nasdaq
- LNTH Nasdaq
- Market Cap
- FLR 6.4B
- LNTH 7.5B
- IPO Year
- FLR N/A
- LNTH 2015
- Fundamental
- Price
- FLR $34.02
- LNTH $97.39
- Analyst Decision
- FLR Strong Buy
- LNTH Strong Buy
- Analyst Count
- FLR 7
- LNTH 6
- Target Price
- FLR $54.29
- LNTH $129.83
- AVG Volume (30 Days)
- FLR 2.7M
- LNTH 790.8K
- Earning Date
- FLR 05-02-2025
- LNTH 05-01-2025
- Dividend Yield
- FLR N/A
- LNTH N/A
- EPS Growth
- FLR 2177.78
- LNTH N/A
- EPS
- FLR 12.30
- LNTH 4.36
- Revenue
- FLR $16,315,000,000.00
- LNTH $1,533,910,000.00
- Revenue This Year
- FLR $13.71
- LNTH $6.59
- Revenue Next Year
- FLR $5.77
- LNTH $11.80
- P/E Ratio
- FLR $2.76
- LNTH $22.30
- Revenue Growth
- FLR 5.43
- LNTH 18.32
- 52 Week Low
- FLR $33.85
- LNTH $58.46
- 52 Week High
- FLR $60.10
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- FLR 34.65
- LNTH 50.29
- Support Level
- FLR $34.69
- LNTH $93.61
- Resistance Level
- FLR $37.49
- LNTH $98.98
- Average True Range (ATR)
- FLR 1.18
- LNTH 3.72
- MACD
- FLR 0.09
- LNTH -0.77
- Stochastic Oscillator
- FLR 3.21
- LNTH 36.37
About FLR Fluor Corporation
Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services. The firm serves a wide range of end markets including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.